Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/08/2008CN101279074A Medicament composite for clearing heat and removing dampness, and relaxing tendons and collaterals, and method of preparing the same
10/08/2008CN101279070A Medicament composite for warming kidney and promoting blood circulation, and dredging channels and collaterals, and method of preparing the same
10/08/2008CN101279058A Pearl health products for improving sleep
10/08/2008CN101279025A Chinese medicine preparation for curing melancholia
10/08/2008CN101279020A Chinese medicinal composition for curing hyperkinetic symptom
10/08/2008CN101278997A Plaster for curing facial paralysis and method of preparing the same
10/08/2008CN101278996A Medicament compound for curing sciatica and method of preparing the same
10/08/2008CN101278985A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278984A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278983A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278961A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/08/2008CN101278949A Composition and its preparation and application
10/08/2008CN101278946A Acetic acid sobering-up active liquid
10/08/2008CN101278942A Application of neural stem cell NSCs-NT3 in repair of neuron damage
10/08/2008CN101278939A Medicament composition for curing cardiovascular and cerebrovascular diseases and method of preparing the same
10/08/2008CN101278926A Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
10/08/2008CN101278925A Application of embellin in preparation of medicament for inhibiting angiogenesis
10/08/2008CN101278924A Meclofenoxate hydrochloride microcapsule and method for preparing injection thereof
10/08/2008CN101278795A Pillow good for sleep and production method
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100424085C Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423776C Therapeutic agent
10/08/2008CN100423753C Method of extracting medicamout having memory strengthening function from natural plant compound preparation
10/08/2008CN100423734C Chinese medicinal honey bolus for treating apoplexia sequel and its mfg. method
10/08/2008CN100423723C Method for treatment of multiple sclerosis
10/08/2008CN100423718C Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
10/08/2008CN100423717C Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
10/08/2008CN100423716C Modafinil pharmaceutical compositions
10/08/2008CN100423709C Pharmaceutical compositions comprising fentanyl for intranasal delivery
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432375 JNK inhibitors
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation
10/07/2008US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
10/07/2008US7432293 Heterocyclic compounds useful as Nurr-1 activators
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008US7432256 Substitued imidazo [1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7431944 One-a-day, oral administration of a methylphenidate drug, e,g, Ritalin, the dosage of which form provides an immediate dose upon ingestion followed by release of more dose(s) later; particles uncoated/coated with ammonio methacrylate
10/07/2008US7431943 Controlled release and taste masking oral pharmaceutical compositions
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2353205C Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
10/07/2008CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
10/07/2008CA2237306C Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
10/07/2008CA2209426C Human pak65
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008119057A2 The use of pde7 inhibitors for the treatment of movement disorders
10/02/2008WO2008118747A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/02/2008WO2008118742A1 Azaadamantane ester and carbamate derivatives and methods of use thereof
10/02/2008WO2008118403A2 Method of using a pkc inhibitor to reverse prefrontal cortical declines
10/02/2008WO2008118100A1 Method of enhancing migration of neural precursor cells
10/02/2008WO2008118093A1 Fusion protein capable of degrading amyloid beta peptide
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117269A2 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
10/02/2008WO2008117169A1 Pyrimido [4, 5-d] azepine derivatives as 5-ht2c agonists
10/02/2008WO2008116959A1 Use of maslinic acid and derivatives thereof for treatment of diseases connected with elastase inhibition, such as neuromas, erythemas, sun and heat burns, and psoriasis
10/02/2008WO2008116845A1 Piperidinone carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116833A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116831A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116816A1 Combination of cb2 ligand and paracetamol
10/02/2008WO2008116814A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
10/02/2008WO2008116663A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
10/02/2008WO2008116648A2 Novel glp-1 fusion peptides, their production and use
10/02/2008WO2008116641A2 Oleyl phosphocholine
10/02/2008WO2008116391A1 The neuroblast proliferation promoter and the neurite outgrowth promoter
10/02/2008WO2008116301A1 Fluorinated derivatives of deferiprone
10/02/2008WO2008099091A3 Use of ivabradine for obtaining drugs for treating endothelial dysfunction
10/02/2008WO2008097897A3 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
10/02/2008WO2008093360A3 A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
10/02/2008WO2008092877A3 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/02/2008WO2008090209A3 Use of glucopyranosyloxy- pyrazoles for preventing and treating neurodegenerative disorders
10/02/2008WO2008080015A3 Compounds and methods for kinase modulation, and indications therefor
10/02/2008WO2008073958A3 Substituted benzothiadiazinedioxide derivatives and methods of their use
10/02/2008WO2008067781B1 A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
10/02/2008WO2008067120A3 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
10/02/2008WO2008059518A3 Process for preparing crystalline aripiprazole
10/02/2008WO2008050698A3 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
10/02/2008WO2007144676A3 Use of echinacea or preparations thereof in compositions for the treatment of anxiety
10/02/2008WO2007101400A8 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
10/02/2008US20080242741 Intranasal drug delivery system
10/02/2008US20080242734 Amantadine therapeutic for treatment and prevention of enterovirus (EV) or encephalomyocarditis virus (EMCV) infection
10/02/2008US20080242728 gabapentin tannate to treat central nervous system disorders; used in sustained release applications and to improve certain organoleptic properties such as taste
10/02/2008US20080242723 for treating or preventing diseases or disorders such as spasticity or gastroesophageal reflux disease; oral dosage formulation
1 ... 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 ... 1833